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Abstract 24 
 25 
The 72-kDa immediate-early 1 (IE1) protein encoded by human cytomegalovirus (hCMV) 26 
is a nuclear-localized promiscuous regulator of viral and cellular transcription. IE1 has 27 
long been known to associate with host mitotic chromatin, yet the mechanisms underlying 28 
this interaction have not been specified. In this study, we identify the cellular chromosome 29 
receptor for IE1. We demonstrate that the viral protein targets human nucleosomes by 30 
directly binding to core histones in a nucleic acid-independent manner. IE1 exhibits two 31 
separable histone interacting regions with differential binding specificities for H2A-H2B 32 
and H3-H4. The H2A-H2B binding region was mapped to an evolutionary conserved ten-33 
amino-acid motif within the chromatin tethering domain (CTD) of IE1. Results from 34 
experimental approaches combined with molecular modeling indicate that the IE1 CTD 35 
adopts a β-hairpin structure docking with the acidic pocket formed by H2A-H2B on the 36 
nucleosome surface. IE1 binds to the acidic pocket in a way similar to the latency-associated 37 
nuclear antigen (LANA) of the Kaposi’s sarcoma-associated herpesvirus. Consequently, the 38 
IE1 and LANA CTDs compete for binding to nucleosome cores and chromatin. Our work 39 
elucidates in detail how a key viral regulator is anchored to human chromosomes and 40 
identifies the nucleosomal acidic pocket as a joint target of proteins from distantly related 41 
viruses. Based on the striking similarities between the IE1 and LANA CTDs and the fact 42 
that nucleosome targeting by IE1 is dispensable for productive replication even in “clinical” 43 
strains of hCMV, we speculate that the two viral proteins may serve analogous functions 44 
during latency of their respective viruses. 45 
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Introduction 46 
 47 
Nuclear DNA is largely organized and controlled through nucleosomes. Each nucleosome 48 
typically assembles 146–147 base pairs (bp) of DNA in 1.65 superhelical turns around a core 49 
histone octamer composed of a central H3-H4 tetramer flanked by two H2A-H2B dimers (1, 2). 50 
Additionally, linker histone H1 binds to the nucleosome at the DNA entry-exit points outside the 51 
octamer. Thousands of nucleosomes along the DNA compose a “beads-on-a-string” array, which 52 
can further condense into higher order chromatin attaining its most compact state during mitosis 53 
(reviewed in 3, 4). 54 
Herpesviruses transcribe, synthesize and package their double-stranded DNA genomes in 55 
the host cell nucleus where they contend with and exploit chromatin to aid viral replication and 56 
persistence. There are several examples of herpesvirus proteins interacting with cellular mitotic 57 
and/or interphase chromatin. The viral proteins attach to chromatin through at least three types of 58 
non-mutually exclusive molecular targets: DNA, histones, or chromatin-associated non-histone 59 
proteins. For instance, Epstein-Barr virus (EBV), a γ-herpesvirus, encodes the EBV nuclear 60 
antigen 1 (EBNA1) which targets host chromatin by interacting with adenosine/thymidine-rich 61 
DNA sequences (5) and EBNA1 binding protein 2 (6-9). In contrast, the latency-associated 62 
nuclear antigen 1 (LANA1 or LANA) encoded by another γ-herpesvirus, Kaposi’s sarcoma-63 
associated herpesvirus (KSHV), associates with chromatin through complex formation with non-64 
histone factors including methyl CpG-binding protein (10) as well as with core histones H2A-65 
H2B (11, 12) and, potentially, linker histone H1 (13). In fact, the crystal structure of a 66 
nucleosome complexed with the first 23 LANA amino acids revealed that the viral peptide forms 67 
a β-hairpin that specifically interacts with an “acidic pocket” formed by the folded regions of the 68 
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H2A-H2B dimer (12). Through chromatin interaction, LANA and other viral proteins assume 69 
fundamental roles in the infectious cycles of their respective viruses (see Discussion). 70 
The 72-kDa immediate-early (IE) 1 protein (IE1-72kDa, IE72, or IE1) is a nuclear 71 
regulatory phosphoprotein of human cytomegalovirus (hCMV), the prototypic β-herpesvirus. IE1 72 
is expressed from the hCMV genome at the onset of infection. Together with the 86-kDa IE2 73 
protein (IE2-86kDa, IE86, or IE2), IE1 is the most prominent member of the major IE (MIE) 74 
family of hCMV gene products which have been assigned critical functions in virus-host 75 
interaction including innate immune modulation and transcriptional regulation (reviewed in 14-76 
16). IE1 is required for viral early gene expression and replication in human fibroblasts, at least 77 
under conditions of low input multiplicity (17-19). Association of IE1 with condensed chromatin 78 
during mitosis was initially described more than 20 years ago (20) and has henceforward been 79 
conspicuous to many researchers (e.g., 21-28). The interaction with mitotic chromatin can be 80 
observed both during hCMV infection and upon ectopic expression of IE1. Chromosome 81 
association was first roughly mapped to MIE exon 4 sequences (20) and, subsequently, to 82 
residues 421 to 486 of the 491-amino-acid viral protein (24). Eventually, the 16 carboxy-terminal 83 
residues (amino acids 476 to 491) of IE1 were determined to be required and sufficient for 84 
mitotic chromatin interaction in transfected cells and were consequently termed the “chromatin 85 
tethering domain” (CTD) (22). The ability for chromosome attachment appears to be 86 
evolutionary conserved between IE1 orthologs of primate CMVs (21, 22, 29). However, despite 87 
being a conserved and distinctive feature of IE1, the mechanisms underlying chromosome 88 
association by the viral protein have not been determined. 89 
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The present study was designed to identify and precisely delineate the molecular 90 
interactions anchoring the hCMV IE1 protein to human chromosomes, and to determine their 91 
impact on viral replication in “clinical” strains of hCMV. 92 
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MATERIALS AND METHODS 93 
 94 
Plasmids and mutagenesis. For expression in human cells, plasmid constructs derived from 95 
pcDNA3 (Life Technologies), pCGN (30), pCMV.TetO (a gift from Roger Everett, University of 96 
Glasgow, Scotland), pEGFP-C1 (Clontech), and pME18S (31) were used. For expression in E. 97 
coli, plasmid constructs derived from pGEX-KG (32) were used. 98 
Plasmid pcDNA-HA-IE1 encodes the hCMV (Towne) 72-kDa IE1 (pUL123) protein 99 
tagged with an Influenza virus hemagglutinin (HA) epitope (21). Plasmid pcDNA-HA-mIE1 100 
encodes an HA-tagged form of the mCMV IE1 (mIE1, pp89) protein and was constructed by 101 
inserting a BamH1-EcoRI fragment from pGEX-mIE1 (21) into the same sites of pcDNA-HA-N 102 
(33) (a gift from Ronald Hay, University of Dundee, Scotland). For construction of pcDNA-HA-103 
IE2, encoding an HA-tagged form of the hCMV 86-kDa IE2 (pUL122) protein, a BglII-EcoRI 104 
fragment from pEGFP-IE2 (21) was inserted into the BamHI and EcoRI sites of pcDNA-HA-N. 105 
Plasmid pCGN-pp71 encodes an HA-tagged form of the hCMV pp71 (pUL82) protein (34). 106 
Plasmid pCMV.TetO.IE1 has been described (40). For pCMV.TetO.IE1M483A, 107 
pCMV.TetO.IE1NBM, and pCMV.TetO.IE11-475, mutant hCMV IE1 (Towne) coding sequences 108 
were PCR-amplified from template pEGFP-TNIE1 (21) with primers 483 and 1085, 483 and 109 
1086, or  483 and 695, respectively, and inserted into the HindIII and EcoRI sites of pCMV-110 
TetO. To generate pEGFP-IE1476-491 and related constructs encoding the enhanced green 111 
fluorescent protein (EGFP) fused to the IE1 CTD or to CTD variants with single amino acid 112 
substitutions (G476A, G477A, K478A, S479A, T480A, M481A, P482A, M483A, V484A, 113 
T485A, R486A, S487A, K488A, A489G, D490A, and Q491A), suitable oligonucleotides (635–114 
636 and 703–734) were annealed and inserted into the BglII and EcoRI sites of pEGFP-C1. A 115 
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construct replacing the first two IE1 coding triplets in pEGFP-IE1476-491 with stop codons 116 
(pEGFP-Stop) was generated in the same way using oligonucleotides 737 and 738. Likewise, 117 
pEGFP-LANA5-22 was generated by ligating annealed oligonucleotides 639 and 640 via BglII and 118 
EcoRI sites with pEGFP-C1. All constructs expressing human histone H2A (H2A.2, type 1-B/E) 119 
were based on pME-Flag-H2A (35) (a gift from Robert Eisenman, Fred Hutchinson Cancer 120 
Research Center, Seattle, USA). To generate constructs encoding Flag-tagged H2A with single 121 
(E41A, E56A, E61A, E64A, D72A, D90A, E91A, E92A, and E121A) and triple 122 
(E61A/E64A/D90A and D90A/E91A/E92A) amino acid substitutions, QuikChange site-directed 123 
mutagenesis (Stratagene) was performed according to the manufacturer’s instructions using 124 
suitable oligonucleotides (787–808).  125 
 In pGEX-KG, the BamHI and EcoRI sites served for all cloning reactions. Plasmid 126 
pGEX-IE1 encodes the hCMV (Towne) 72-kDa IE1 protein fused to GST (21). To generate 127 
pGEX-IE11-475, a PCR product amplified from template pGEX-IE1 with primers 637 and 638 was 128 
digested with BamHI and EcoRI and ligated with pGEX-KG. For construction of pGEX-IE1476-129 
491 and related constructs encoding GST fused to the IE1 CTD or to CTD variants with single 130 
amino acid substitutions, suitable oligonucleotides (635–636 and 703–734) were annealed and 131 
ligated with pGEX-KG. A construct replacing the first two IE1 coding triplets in pGEX-IE1476-491 132 
with two stop codons (pGEX-Stop) was generated in the same way using oligonucleotides 737 133 
and 738. Likewise, pGEX-LANA5-22 was generated by ligating annealed oligonucleotides 639 134 
and 640 with pGEX-KG. To construct pGEX-PreS-IE1, a DNA fragment encoding the 135 
recognition motif for PreScission Protease (LEVLFQGP) between the GST and IE1 sequences 136 
was generated by overlap extension PCR (36) from templates pGEX-KG and pGEX-IE1 with 137 
primers 484 and 603–605. The PCR product was digested with BamHI and EcoRI and ligated 138 
with pGEX-IE1. Plasmid pGEX-PreS-IE1 was used as a template for PCR with primers 695 and 139 
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838 resulting in a DNA fragment that was digested with BamHI and EcoRI and ligated with 140 
pGEX-PreS-IE1 to produce pGEX-PreS-IE11-475. Finally, pGEX-PreS-IE1476-491, pGEX-PreS-141 
LANA5-22, and pGEX-PreS were generated by ligating annealed oligonucleotides 834 and 835, 142 
836 and 837, or 658 and 659, respectively, with pGEX-PreS-IE1. 143 
As a standard for absolute quantification of hCMV genome copies by real-time quantitative 144 
PCR (qPCR), plasmid pCR-RPPH1-UL54P was constructed by a two-step procedure. First, a 145 
PCR product comprising 71 bp of hCMV UL54 promoter (UL54P) sequence was amplified from 146 
an infected cell genomic DNA template with primers 294 and 295, and was ligated with pCR4-147 
TOPO (Life Technologies). Secondly, the resulting construct (pCR-UL54P) was cleaved with 148 
PmeI and ligated with a PCR product comprising 83 bp of human ribonuclease P RNA 149 
component H1 (RPPH1) sequence amplified from an infected cell genomic DNA template with 150 
primers 759 and 765. All oligonucleotide sequences are listed in Table S1. 151 
 152 
Cells, viruses, and infections. Human fetal diploid lung fibroblasts (MRC-5) (37) were 153 
obtained from the European Collection of Cell Cultures, and early-passage cells (15 to 25 154 
population doublings before senescence) were used in all experiments. MRC-5-derived TetR 155 
cells and TetR-IE1 cells expressing inducible wild-type IE1 have been described (40). TetR-IE11-156 
475 cells expressing inducible CTD-deleted IE1 were generated via lentiviral transduction 157 
analogous as described for TetR-IE1 cells (40). The H1299 human lung carcinoma cell line (38) 158 
was obtained from the American Type Culture Collection. MRC-5 and H1299 cells were grown 159 
in Dulbecco's Modified Eagle's Medium (DMEM) (Life Technologies) supplemented with 10% 160 
fetal calf serum (Life Technologies), 100 U/ml penicillin, and 100 µg/ml streptomycin. For TetR, 161 
TetR-IE1, and TetR-IE11-475 cells, the same medium was further supplemented with 1 µg/ml 162 
puromycin and 300 µg/ml G418, and induction of IE1 or IE11-475 expression was accomplished 163 
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by adding doxycycline (1 µg/ml) 72 h prior to collection. All cells were maintained under 164 
humidified conditions at 37°C and 5% CO2. Cultures were regularly screened for mycoplasma 165 
contamination. 166 
 The wild-type (TNwt) and IE1-deficient (TNdlIE1) viruses of the high passage hCMV 167 
Towne strain (39) were described previously (21, 40, 41). The wild-type (TBwt) virus of the low 168 
passage hCMV TB40E strain (42) was derived from TB40-BAC4 (43) (a gift from Christian 169 
Sinzger, Ulm University, Germany). For the construction of TB40E-based IE1 CTD-deficient 170 
bacterial artificial chromosomes (BACs) (pTBIE11-475) by en passant mutagenesis, E. coli strain 171 
GS1783 (44) carrying TB40-BAC4 was transformed with a DpnI-digested and column-purified 172 
PCR product generated using plasmid pLAY2 (45) (a gift from Karsten Tischer, Freie University 173 
Berlin, Germany) as a template and oligonucleotides 870 and 871 as primers. “Scarless” removal 174 
of CTD-specific sequences by homologous recombination was accomplished following published 175 
protocols (44). To control for inadvertent genetic changes, the en passant strategy was also 176 
employed to construct “revertant” BACs (pTBrvIE11-475). To this end, a PCR product comprising 177 
MIE exon 4 was generated using TB40-BAC4 as a template and oligonucleotides 876 and 877 as 178 
primers. This PCR product was inserted into pUC18 via HindIII and EcoRI sites resulting in 179 
plasmid pUC-MIE. In addition, a PCR product comprising a kanamycin resistance (kan) cassette 180 
and an SceI cleavage site was generated, using pLAY2 as a template and oligonucleotides 878 181 
and 879 as primers. Following cleavage with NcoI, this PCR product was inserted into the NcoI 182 
site of pUC-MIE resulting in plasmid pUC-MIE-kan_SceI. Then, GS1783 bacteria carrying BAC 183 
pTBIE11-475 were transformed with a DpnI-digested and column-purified PCR product generated 184 
using plasmid pUC-MIE-kan_SceI as a template and oligonucleotides 880 and 881 as primers, 185 
and this was followed by homologous recombination (44). The identity and integrity of pTBIE11-186 
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475 and pTBrvIE11-475 were verified in comparison to TB40-BAC4 by restriction fragment length 187 
and DNA sequencing analyses (data not shown). 188 
 Allelic exchange to generate IE1 CTD-deficient (pFXIE11-475) and revertant (pFXrvIE1) 189 
BACs of the low passage hCMV FIX strain (46, 47) utilized the following derivatives of transfer 190 
plasmid pGS284 (48) (amplified in E. coli strain S17λpir): pGS284-FXIE1kanlacZ, pGS284-191 
FXMIE, and pGS284-FXIE11-475. Plasmid pGS284-FXIE1kanlacZ contains the kan and lacZ 192 
genes cloned between sequences flanking the IE1-specific exon four of the hCMV FIX MIE 193 
transcription unit. The ~1,000-bp flanking sequences were obtained by PCR amplification using 194 
primers 136 and 138 (downstream flanking sequence) or 139 and 140 (upstream flanking 195 
sequence), and an EGFP expressing hCMV FIX BAC (pFXwt) (a gift from Dong Yu, 196 
Washington University School of Medicine, USA) as template. The amplified downstream 197 
flanking sequence was cloned into pGS284 via BglII and NotI sites. Following addition of 198 
adenosine nucleotide overhangs to the PCR product, the upstream flanking sequence was first 199 
subcloned into vector pCR4-TOPO (Life Technologies) and subsequently inserted via NotI sites 200 
into pGS284 carrying the downstream flanking sequence. The kanlacZ expression cassette was 201 
released from plasmid pGEM-kanlacZ (YD-C54) (49) and cloned into the PacI site located 202 
between the hCMV flanking sequences in the pGS284 derivative described above. For the 203 
construction of pGS248-FXMIE, a ~3,000-bp sequence of the MIE region was amplified by PCR 204 
using template pFXwt and primers 155 and 156. After phosphorylation, the PCR product was 205 
first inserted into the SmaI site of pUC18 to generate pUC18-FXMIE. Plasmid pUC18-FXMIE 206 
served as a template for QuikChange site-directed mutagenesis with oligonucleotides 280 and 207 
281 replacing IE1 codon 475 with a stop codon to generate pUC18-FXIE11-475. Then, FseI-NotI 208 
fragments were excised from pUC18-FXMIE and pUC18-FXIE11-475 and cloned into the same 209 
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sites of pGS284-FXIE1kanlacZ thereby generating pGS284-FXMIE and pGS284-FXIE11-475, 210 
respectively. For verification, DNA sequence analysis was completed on all cloned PCR 211 
amplification products. Allelic exchange was performed through homologous recombination in 212 
E. coli strain GS500 as previously described (21, 48, 49). First, the BAC pFXIE1kanlacZ was 213 
generated by recombination of pFXwt with pGS284-FXIE1kanlacZ followed by selection for 214 
kanamycin resistance and LacZ expression. After that, the BACs pFXIE11-475 and pFXrvIE1 were 215 
made through recombination of pFXIE1kanlacZ with pGS284-FXIE11-475 and pGS284-FXMIE, 216 
respectively, followed by selection for the loss of kanamycin resistance and LacZ expression. The 217 
identity and integrity of pFXIE11-475 and pFXrvIE1 were verified in comparison to pFXwt by 218 
restriction fragment length and DNA sequence analyses (data not shown). All oligonucleotide 219 
sequences are listed in Table S1. 220 
 Cell- and serum-free virus stocks were produced upon electroporation of MRC-5 cells with 221 
BAC clones carrying wild-type (TNwt, FXwt, TBwt), revertant (FXrvIE1, TBrvIE11-475), or IE1 222 
CTD-deficient (FXIE11-475, TBIE11-475) genomes. Stocks of TNdlIE1 viruses were produced in a 223 
similar fashion, following electroporation of TetR-IE1 cells (40). All virus stocks were screened 224 
for mycoplasma contamination. Titers were calculated by qPCR-based absolute quantification of 225 
intracellular viral genome copies following infection of MRC-5 cells as described (21, 40) and by 226 
comparing the results to a standard curve based on amplifications from plasmid pCR-RPPH1-227 
UL54P (see above) mixed with salmon sperm DNA. For wild-type viruses, titers were also 228 
determined by standard plaque assay on MRC-5 cells. For mutant and revertant viruses, plaque 229 
forming units relative to wild-type titers were calculated from intracellular viral copy numbers. 230 
Infections were carried out at the indicated input multiplicities and for the indicated durations on 231 
(nearly) confluent MRC-5 cells. 232 
 233 
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Protein production, purification, and analysis. For protein production in E. coli, a single 234 
colony of the Rosetta strain (Novagen) transformed with pGEX-KG or derivatives was grown by 235 
shaking (220 revolutions per minute [rpm]) overnight at 28°C in Luria-Bertani medium 236 
containing ampicillin (50 μg/ml), chloramphenicol (20 μg/ml), and 2% glucose. On the next day, 237 
the culture was diluted to an optical density at 600 nm (OD600) of 0.1 with fresh prewarmed 238 
medium lacking glucose and further grown for 2–3 h at 220 rpm and 28°C to an OD600 of 0.6. At 239 
this point, gene expression was induced by adding isopropyl-β-D-thiogalactopyranoside to a final 240 
concentration of 200 µM. Following a 6-h incubation at 220 rpm and 28°C, cells were quick-241 
chilled on ice and collected by centrifugation (~2,500×g, 15 min, 4°C). Bacteria were 242 
resuspended in 1/10 culture volume ice-cold wash buffer (50 mM Tris-HCl [pH 7.5], 150 mM 243 
NaCl, 2 mM MgCl2, 1 mM DTT, cOmplete EDTA-free Protease Inhibitor Cocktail [Roche]). 244 
After another round of centrifugation (~2,500×g, 15 min, 4°C), the pellet was resuspended in 245 
1/25 culture volume ice-cold wash buffer containing 1 mM phenylmethylsulfonyl fluoride (added 246 
freshly). The suspension was snap-frozen in liquid nitrogen and stored at -80°C. 247 
To purify GST and GST fusion proteins, bacteria suspended in wash buffer (see above) 248 
were thawed in a water bath at room temperature. For the subsequent workflow, ice-cold buffers 249 
and solutions were used, and all steps were carried out on ice or at 4°C. Following addition of 250 
lysozyme (150 µg/ml) and benzonase (25 U/ml), the suspension was sonicated five times for 1 251 
min using a Branson Sonifier 450 (duty cycle 80%, output control 2) to facilitate cell lysis. The 252 
lysate was combined with 1/9 volume wash buffer containing 10% Triton X-100, rotated for 30 253 
min to solubilize proteins, and centrifuged (20,000×g, 30 min). The affinity matrix was prepared 254 
by washing Glutathione Sepharose 4B (GE Healthcare) consecutively in ten bed volumes 255 
equilibration buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 2 mM MgCl2), 10 bed volumes 256 
blocking buffer (equilibration buffer with 2% bovine serum albumin) (1 h under rotation), and 257 
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another 10 volumes equilibration buffer. After that, 1.25 ml equilibrated matrix per 1,000 ml 258 
culture volume and the supernatant from the bacterial lysate were combined and rotated for 2 h. 259 
The sample was then applied to a 10-ml Pierce Centrifuge Column (Thermo Scientific), and the 260 
matrix was washed consecutively with 50 bed volumes low salt wash buffer (50 mM Tris-HCl 261 
[pH 7.5], 150 mM NaCl, 1 mM dithiothreitol [DTT], 1% Triton X-100, 1 mM EDTA, cOmplete 262 
EDTA-free Protease Inhibitor Cocktail), 50 bed volumes high salt wash buffer (50 mM Tris-HCl 263 
[pH 7.5], 500 mM NaCl, 1 mM DTT, 1% Triton X-100, 1 mM ethylenediaminetetraacetic acid 264 
(EDTA), cOmplete EDTA-free Protease Inhibitor Cocktail), and another 50 bed volumes low salt 265 
wash buffer. After the final washing step, one bed volume low salt wash buffer was added, the 266 
column was sealed, and the 50% slurry containing purified proteins was stored in ice until use. 267 
To remove the GST tag from GST-IE1 and GST-IE11-475, the protein-loaded matrix was washed 268 
with 50 bed volumes cleavage buffer (PBS with 1 mM DTT), the column outlet was sealed, and 269 
one bed volume of cleavage buffer containing PreScission protease (50 U/ml, GE Healthcare) 270 
was added. Protein cleavage was allowed to proceed in the sealed column for 16 h under rotation. 271 
After that, the flow-through containing IE1 or IE11-475 proteins was collected. Protein 272 
concentrations were calculated assuming absorption at 280 nm values of 0.396 or 0.409 for 1 273 
g/1,000 ml (0.1%) IE1 or IE11-475, respectively. 274 
For preparation of nucleosomes, H1299 cells grown to confluency were scraped on ice and 275 
collected in 15-ml tubes by centrifugation (500×g, 5 min, 4°C). For the subsequent workflow, 276 
ice-cold buffers and solutions were used, and all steps were carried out on ice or at 4°C. Cell 277 
pellets, each corresponding to one 10-cm plate, were resuspended in 1 ml MNase lysis buffer (10 278 
mM Tris-HCl [pH 7.4], 10 mM NaCl, 3 mM MgCl2, 150 µM spermine, 500 µM spermidine, 279 
0.5% IGEPAL CA-630) and vortexed while simultaneously adding another 4 ml MNase lysis 280 
buffer. Following a 5-min incubation, samples were centrifuged (300×g, 5 min), the supernatant 281 
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was removed completely, and nuclei were washed in 500 µl MNase reaction buffer (10 mM Tris-282 
HCl [pH 7.4], 15 mM NaCl, 60 mM KCl, 150 µM spermine, 500 µM spermidine). After that, 283 
nuclei were carefully resuspended in 100 µl MNase reaction buffer with 1 mM CaCl2 and 284 
prewarmed for exactly 5 min at 30°C. Extra-nucleosomal DNA was digested by adding 100 U 285 
Nuclease S7 MNase from Staphylococcus aureus (Roche) diluted in MNase dilution buffer (5 286 
mM Tris-HCl [pH 7.4], 10 µM CaCl2). Following incubation for 10 min at 30°C, reactions were 287 
stopped with 20 mM EDTA and 2 mM ethylene glycol tetraacetic acid. For co-288 
immunoprecipitations, nucleosome preparations (120 µl) were combined with whole cell extracts 289 
prepared as described above. 290 
Histones were purified by acid extraction from H1299 cell nuclei. Cells grown to 291 
confluency were scraped on ice and collected in 15-ml tubes by centrifugation (500×g, 5 min, 292 
4°C). For the subsequent workflow, ice-cold buffers and solutions were used, and all steps were 293 
carried out on ice or at 4°C. Cell pellets, each corresponding to one 15-cm plate, were 294 
resuspended in 1 ml hypotonic lysis buffer (10 mM Tris-HCl [pH 7.5], 10 mM NaCl, 3 mM 295 
MgCl2, 10 mM DTT, 0.5% IGEPAL CA-630, EDTA-free Protease Inhibitor Cocktail Set III). 296 
Then, 4 ml hypotonic lysis buffer were added while samples were concomitantly vortexed at 297 
medium speed. Following a 5-min incubation, nuclei were collected by centrifugation (500×g, 5 298 
min) and washed by repeating the consecutive 1-ml and 4-ml resuspension steps in hypotonic 299 
lysis buffer twice (without the 5-min incubation in between). Following centrifugation (500×g, 1 300 
min), the supernatant was removed completely, the pellet was resuspended in 1 ml 200 mM 301 
H2SO4, and the nuclei were transferred to 1.5-ml tubes. After that, samples were incubated for 16 302 
h on a rotator. Following extraction, samples were centrifuged (20,000×g, 30 min) to remove 303 
insoluble debris, and 900 µl supernatant were transferred to a new 1.5-ml tube. Histones were 304 
precipitated by addition of trichloroacetic acid (TCA) to a final concentration of 35% and 305 
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overnight incubation at -20°C. After centrifugation (20,000×g, 15 min), the protein pellet was 306 
washed by sonication (Branson Sonifier 450; 10 pulses, duty cycle 80%, output control 8) in 1 ml 307 
acetone with 50 mM HCl and, subsequently, in 1 ml pure acetone at room temperature. After a 308 
final centrifugation step (20,000×g, 15 min), pellets were dried at room temperature. For binding 309 
assays, histones were resuspended in an appropriate volume of reaction buffer by sonication 310 
(Branson Sonifier 450; 10 pulses, duty cycle 80%, output control 8) and repeated pipetting. 311 
For separation of histones into fractions containing either H2A-H2B or H3-H4, the 312 
purification protocol was extended by an ion exchange chromatography step (50) following acid 313 
extraction. Briefly, a 2-ml Pierce Centrifuge Column was filled with 1 ml Sulfopropyl-Sepharose 314 
Fast Flow (Sigma-Aldrich) and washed twice with 8.1 ml wash buffer I (50 mM Tris-HCl [pH 315 
8.0], 200 mM NaCl, 2 mM EDTA). Concurrently, histone extracts (prepared as described above) 316 
from six 15-cm dishes of H1299 cells were pooled in a 50-ml tube and combined with 2 volumes 317 
of 1 M Tris-HCl (pH 8.0). After verifying the pH (pH 7.0–8.0), 200 mM NaCl, 1 mM DTT, and 2 318 
mM EDTA were added, and the mixture was applied to the filled column. The column was 319 
washed with 8.1 ml wash buffer II (50 mM Tris-HCl [pH 8.0], 500 mM NaCl, 2 mM EDTA [pH 320 
8.0]) and, subsequently, with the same volume of wash buffer III (50 mM Tris-HCl [pH 8.0], 600 321 
mM NaCl, 2 mM EDTA). For elution of H2A-H2B, 6.6 ml elution buffer I (50 mM Tris-HCl [pH 322 
8.0], 800 mM NaCl, 2 mM EDTA) were added to the column, of which the first 600 µl were 323 
discarded and six 1-ml fractions were collected. Following two 8.1-ml wash steps with elution 324 
buffer I, H3-H4 was eluted with 2.5 ml elution buffer II (50 mM Tris-HCl [pH 8.0], 2 M NaCl, 2 325 
mM EDTA) and collected in five 500 µl-fractions. A subset of histone fractions (determined by 326 
polyacrylamide-sodium dodecyl sulfate [SDS] gel electrophoresis and Coomassie Brilliant Blue 327 
staining, see below) were pooled and subjected to TCA precipitation as described above. 328 
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 For protein analysis, samples were mixed with 2×loading buffer (100 mM Tris-HCl [pH 329 
6.8], 4% SDS, 20% glycerol, 0.2% bromphenol blue, 200 mM β-mercaptoethanol), denatured for 330 
5 min at 95°C, and separated in SDS-polyacrylamide gels that were either stained with 331 
Coomassie Brilliant Blue (PlusOne Coomassie Blue PhastGel R-350, GE Healthcare) according 332 
to the manufacturer’s instructions, or subjected to immunoblotting including chemiluminescent 333 
detection (SuperSignal West Pico or SuperSignal West Femto, Thermo Scientific) as described 334 
(51). The following antibodies were used for protein detection following blotting: α-Flag (M2, 335 
Sigma-Aldrich), α-GAPDH (ab9485, Abcam), α-HA (3F10, Roche), α-H2A (ab13923, Abcam), 336 
α-H2B (ab1790, Abcam), α-H3 (ab1791, Abcam), α-H4 (62-141-13, Upstate), α-IE1 (1B12, 337 
[52]; ab30924 [IE1.G10], Abcam; 6E1, Santa Cruz), α-IE1/IE2 (MAB810R, Merck Millipore), 338 
and horseradish peroxidase-coupled anti-mouse (115-036-003, Dianova), anti-rabbit (AP156P, 339 
Chemicon), or anti-rat (112-035-003, Dianova) secondary conjugates. 340 
 341 
Protein binding and competition analysis. For co-immunoprecipitations, subconfluent 342 
H1299 cells on 10-cm plates were transfected with 10 µg plasmid DNA using a calcium 343 
phosphate precipitation technique (53). Approximately 48 h post transfection, cells were stored at 344 
room temperature for 10 min and cross-linked by adding formaldehyde to a final concentration of 345 
1% directly to the medium. Following a 5-min incubation at room temperature, a glycine solution 346 
(125 mM final concentration) was added to each dish to terminate cross-linking. After another 5-347 
min incubation at room temperature, the medium was removed, and cells were washed twice with 348 
10 ml ice-cold serum-free DMEM. For the subsequent workflow, ice-cold buffers and solutions 349 
were used, and all steps were carried out on ice or at 4°C. Cells were scraped into 2 ml serum-350 
free DMEM with EDTA-free Protease Inhibitor Cocktail Set III (Merck Millipore), and each dish 351 
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was washed three times with 2.5 ml serum-free DMEM for optimal cell recovery. After that, cells 352 
were centrifuged (2,500×g, 10 min), and the medium was removed completely. The cell pellet 353 
was resuspended in 1 ml immunoprecipitation (IP) lysis buffer (50 mM Tris-HCl [pH 7.5], 125 354 
mM NaCl, 500 µM DTT, 0.5% IGEPAL CA-630, 1% Triton X-100, 5 mM EDTA, EDTA-free 355 
Protease Inhibitor Cocktail Set III), and the suspension was incubated for 5 min. After 356 
centrifugation (12,000×g, 1 min), the pellet was washed in IP lysis buffer, recentrifuged 357 
(12,000×g, 1 min), resuspended in IP lysis buffer, and incubated for 10 min. Then, the cell lysate 358 
was sonicated three times for 5 min in a Bioruptor UCD-200 (Diagenode; position “H”, 30 s on-359 
off cycle) to shear the chromatin. After that, insoluble debris was removed by centrifugation 360 
(20,000×g, 30 min), and 900 µl supernatant were transferred to a new 1.5-ml tube. The following 361 
matrices were used for the subsequent immunoprecipitation reactions: Anti-Flag M2 Affinity Gel 362 
(Sigma-Aldrich), Monoclonal Anti-HA-Agarose (HA-7, Sigma-Aldrich), Mouse IgG-Agarose 363 
(Sigma-Aldrich), or Protein A Agarose/Salmon Sperm DNA (Merck Millipore). Before use, 364 
agarose beads were washed three times in 1 ml IP lysis buffer. To preclear the lysate, 100 µl (20 365 
µl bed volume) Mouse IgG-Agarose or Protein A Agarose/Salmon Sperm DNA were added, and 366 
the mixture was rotated for 1 h. Following centrifugation (20,000×g, 30 min), 50 µl supernatant 367 
were removed to serve as input sample and 850 µl were transferred to a new 1.5-ml tube. For 368 
reactions using Protein A Agarose/Salmon Sperm DNA, the lysate was incubated overnight with 369 
α-H3 antibodies (ab1791, Abcam) or IgG from rabbit serum (Sigma-Aldrich). Then, 100 µl (20 370 
µl bed volume) of the respective antibody-coupled or Protein A agarose matrix were added. After 371 
rotation for 1 h, samples were centrifuged (100×g, 1 min), and the supernatant was removed 372 
completely. The protein-loaded matrix was resuspended in 100 µl DNase buffer (Ambion) and 373 
reacted with 2 µl (4 U) DNase I (Ambion) for 15 min at 25°C. After that, 1 ml IP lysis buffer was 374 
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added, and the matrix was washed five times in the same buffer. Following the final 375 
centrifugation step (100×g, 1 min), the pellet was resuspended in 45 µl 1×loading buffer, and 376 
samples were heated (10 min for output and 5 min for input samples). Before electrophoresis, 377 
output samples were centrifuged (16,000×g, 5 min), and only the supernatant was used for 378 
immunoblotting. 379 
For GST pull-down assays, ice-cold buffers and solutions were used, and all steps were 380 
carried out on ice or at 4°C. For each reaction, 20 µl (bed volume) Glutathione Sepharose 4B (GE 381 
Healthcare) loaded with GST or GST fusion proteins were washed twice in 700 µl binding buffer 382 
(50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM DTT, 10% glycerol, 0.5% Triton X-100, 383 
EDTA-free Protease Inhibitor Cocktail Set III). Acid-extracted histones from one half 15-cm dish 384 
of H1299 cells in 300 µl binding buffer were subjected to one 10 min and two 5 min 385 
centrifugations (20,000×g) to remove insoluble debris. The histone solution was subsequently 386 
combined with the washed protein-loaded sepharose matrix, and 10% of the total volume was 387 
removed to serve as input sample. The suspension was rotated for 90 min to facilitate binding. 388 
After that, the matrix was washed five times in 700 µl binding buffer, resuspended in 100 µl 389 
1×loading buffer, heated, and analyzed. 390 
 To analyze competition between IE1 and LANA for nucleosome/histone binding, synthetic 391 
peptides encompassing KSHV LANA residues 5 to 22 (LANA-CTD: 392 
GMRLRSGRSTGAPLTRGS) or a mutant amino acid sequence deficient for histone binding 393 
(LANA-CTD*: GMRAAAGRSTGAPLTRGS) were purchased from Thermo Scientific and 394 
dissolved in water. IE1 and IE11-475 proteins were derived from the respective GST fusion 395 
proteins by cleavage with PreScission protease (GE Healthcare). Acid-extracted histones in 396 
binding buffer were preincubated for 1 h with various concentrations of LANA-CTD or LANA-397 
CTD* (1 mM stock solution), IE1 (95 µM stock solution), or IE11-475 (83 µM stock solution). 398 
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After that, the samples were centrifuged (20,000×g, 15 min), and the supernatant was reacted 399 
with the respective GST or GST fusion proteins coupled to Glutathione Sepharose 4B as 400 
described above. 401 
For protein quantification, bands were scanned at 72 dots per inch and subjected to 402 
densitometry using Scion Image 4.0.2 software (Scion Corporation) including the GelPlot2 403 
extension. 404 
 405 
Immunofluorescence and microscopy. Subconfluent H1299 or MRC-5 cells grown on 406 
sterile coverslips in 6-well dishes were transfected with 5 µg plasmid DNA using a calcium 407 
phosphate precipitation technique (53). Alternatively, MRC-5 cells were mock- or hCMV-408 
infected as described in Supplemental Material. Approximately 48 h post transfection or 409 
infection, cells were washed three times with phosphate-buffered saline (PBS) containing 0.05% 410 
Tween 20 (PBS-T) and fixed with ice-cold methanol for 20 min at -20°C. After three 5-min 411 
washes with PBS-T, samples were blocked for 1 h in PBS-T containing 2% bovine serum 412 
albumin (BSA) and reacted for 1 h with the respective primary antibodies in a humidity chamber. 413 
The primary antibodies used for immunofluorescence were α-EGFP (ab290, Abcam) or α-IE1 414 
(ab30924 [IE1.G10], Abcam; sc-69834 [6E1], Santa Cruz). Following three 5-min washes with 415 
PBS-T and a 1-h incubation with the appropriate Alexa Fluor 488- and Alexa Fluor 594-416 
conjugated secondary antibodies (Life Technologies) and 0.2 μg/ml 4′,6-diamidino-2-417 
phenylindole (DAPI) (Roche), coverslips were mounted on glass slides using ProLong Gold (Life 418 
Technologies). Slides were analyzed using a Keyence BZ 9000 (Generation II) or a Leica DMRX 419 
epifluorescence microscope equipped with a digital camera system (Retiga, Q-Imaging), and 420 
images were acquired and processed using BZ II Analyzer (Keyence) or Image-Pro Plus (version 421 
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6.2) (Q-Imaging) and Adobe Photoshop CS4 software. The extent of overlap between pixels in 422 
the green and blue channels was quantified by calculating Pearson’s correlations from 423 
autocontrasted eight bit images using ImageJ software (National Institutes of Health) and the 424 
Colocalization_Finder (version 1.2) plugin (http://rsb.info.nih.gov/ij/plugins/colocalization-425 
finder.html). 426 
 427 
Molecular modeling. Homology modeling was performed using the PERMOL module 428 
(54) implemented in the AUREMOL package (55). The 16 carboxy-terminal residues (amino 429 
acids 476–491) of hCMV (Towne) IE1 were aligned with 14 amino-terminal residues (amino 430 
acids 4–17) of KSHV LANA using a program based on the Needleman-Wunsch algorithm 431 
contained in PERMOL. The alignment was confirmed with other programs including ClustalW2 432 
(http://www.ebi.ac.uk/tools/msa/clustalw2) and EMBOSS Stretcher 433 
(http://www.ebi.ac.uk/tools/psa/emboss_stretcher), respectively. An alternative alignment was 434 
produced by just one of all tested programs (LALIGN; http://www.ebi.ac.uk/tools/psa/lalign). 435 
Other possible alignments were excluded as they did not involve the nucleosome binding motif 436 
(GMRLRSG) of the LANA CTD. As a template for homology modeling, we used the x-ray 437 
structure of the LANA4-17-nucleosome complex (12) (PDB: 1zla). The modeling was restricted to 438 
the interaction site of the LANA peptide with histones H2A and H2B, i.e., LANA amino acids 4–439 
17, H2A amino acids 14–107, and H2B amino acids 30–122 could evolve using restrained 440 
molecular dynamics while the remaining part of the histone complex was held rigid during the 441 
calculations. For the modeling, the LANA peptide was replaced by the IE1 CTD using either of 442 
the two reasonable amino acid sequence alignments. In a second step, we used PERMOL to 443 
generate interatomic distance restraints, dihedral angle restraints, and hydrogen bonds from the 444 
H2A-H2B/IE1 CTD model template based on the degree of sequence conservation between the 445 
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LANA and IE1 CTDs. With this set of restraints, 1,000 structures were calculated per each model 446 
using the molecular dynamics program Crystallography & NMR System (56, 57). The twenty 447 
best structures in terms of total energy were used for explicit water refinement (58). After the 448 
water refinement, a bundle of the ten lowest energy structures was selected for each of the two 449 
models. 450 
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RESULTS 451 
 452 
IE1 interacts with nucleosomes in a nucleic acid-independent fashion. We started the work by 453 
employing immunoprecipitation-immunoblotting analysis to investigate whether IE1 and other 454 
nuclear localized CMV proteins are physically associated with nucleosomes. For the first set of 455 
binding assays, extracts from cells transfected either with empty vector or with plasmids 456 
encoding epitope-tagged hCMV IE1, murine cytomegalovirus (mCMV) IE1 (mIE1), hCMV IE2, 457 
and hCMV pp71 were combined with exogenous nucleosomes prepared by micrococcal nuclease 458 
(MNase) digestion of human cell nuclei. Readily detectable amounts of core histones from all 459 
four classes (H2A, H2B, H3, and H4) were found to co-precipitate with IE1, while much smaller 460 
amounts were detected with IE2. Very little, if any, histone binding was observed in the mIE1, 461 
pp71, and empty vector transfections. Likewise, a non-specific antibody did not precipitate any 462 
appreciable amounts of core histones (Fig. 1A). In a second round of experiments, we checked 463 
for co-precipitation of endogenous nucleosomes solubilized by sonication with epitope-tagged 464 
IE1, mIE1, IE2, and pp71. Under these conditions, specific core histone binding could only be 465 
demonstrated for IE1, but not for any of the other viral proteins under investigation (Fig. S1). 466 
Importantly, IE1 was found to specifically interact with endogenous core histones not only in 467 
plasmid-transfected but also in hCMV-infected cells (Fig. 1B). 468 
To confirm the results obtained by immunoprecipitation-immunoblotting in another type of 469 
binding assay, we expressed IE1 fused to glutathione S-transferase (GST) in Escherichia coli and 470 
affinity-purified the protein on glutathione sepharose beads. GST-IE1 beads and beads loaded 471 
with only GST or no protein (empty beads) were subsequently reacted with acid-extracted 472 
histones, and samples were analyzed by electrophoresis in polyacrylamide gels stained with 473 
- 23 - 
 
Coomassie Brilliant Blue. The four core histones were found to interact with GST-IE1 at an 474 
approximately equimolar ratio, while only minor binding to GST or empty beads was observed in 475 
these assays (Fig. 1C). IE1 is not believed to bind DNA or RNA directly, and acid-extracted 476 
histone preparations are not supposed to contain intact nucleic acids. However, to fully rule out 477 
the possibility that the observed IE1-histone interactions are mediated through DNA or RNA, the 478 
pull-down assays were repeated in the presence of excess amounts of nucleases (DNase I and 479 
RNase A). As expected, the results obtained from DNase- and RNase-treated samples were 480 
virtually indistinguishable from those obtained in the absence of nucleases (Fig. 1C). 481 
Taken together, the results from our in vivo and in vitro interaction assays demonstrate that 482 
IE1 specifically binds to human nucleosome cores, most likely through direct interaction with 483 
histones. 484 
 485 
IE1 interacts with core histones via two separable regions with distinct binding 486 
specificities. To investigate whether core histones interact with IE1 residues previously shown to 487 
be required for chromosome association (22), we constructed plasmids encoding GST fused 488 
either to a carboxy-terminally truncated IE1 lacking the CTD (GST-IE11-475) or to an amino-489 
terminally truncated IE1 consisting of only the CTD (GST-IE1476-491). We also generated a 490 
plasmid encoding GST fused to the KSHV LANA amino-terminal CTD (GST-LANA5-22) (59, 491 
60), which was shown to bind to the H2A-H2B dimer of the nucleosome (12, 61) (Fig. 2A). 492 
Following expression in E. coli, the GST fusion proteins were used in pull-down assays with 493 
acid-extracted histone preparations as described above for wild-type GST-IE1 (see Fig. 1C). With 494 
GST-IE11-475, a reduction in H2A and H2B binding was evident compared to the full-length 495 
protein, whereas H3 and H4 binding was not negatively affected. Conversely, GST-IE1476-491 and 496 
GST-LANA5-22 did not specifically interact with H3 and H4. Instead, both GST-IE1476-491 and 497 
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GST-LANA5-22 displayed selective affinity for H2A and H2B. The interaction between H2A-498 
H2B and GST-IE1476-491 was less efficient compared to full-length GST-IE1, but about equally 499 
efficient compared to GST-IE11-475 and GST-LANA5-22. No interaction between any of the GST 500 
proteins and linker histone H1 was detected (Fig. 2B). Notably, CTD-mediated complex 501 
formation between IE1 and H2A or H2B was also observed in co-immunoprecipitations from 502 
cells arrested in interphase (G0 phase), indicating that nucleosome targeting by the viral protein is 503 
not restricted to mitosis (Fig. S2). 504 
To discriminate between direct and indirect core histone interactions, acid-extracted 505 
histones were further purified and separated into fractions highly enriched for either H2A-H2B 506 
dimers or H3-H4 dimers/tetramers. As predicted from the preceding experiments (see Fig. 2B), 507 
GST-IE11-475 and GST-IE1476-491 displayed H2A-H2B binding comparable to GST-LANA5-22 but 508 
less efficient compared to full-length GST-IE1. By contrast, GST-IE1 and GST-IE11-475 were 509 
equally efficient in binding to H3-H4. Finally, for GST-IE1476-491 and GST-LANA5-22 no H3-H4 510 
interaction above background was observed (Fig. 2C). 511 
The results from these experiments allow for several conclusions: (i) IE1 binds to core 512 
histones through at least two physically separable (and therefore independent) interaction 513 
surfaces, i.e., the CTD and unspecified sequences located upstream from the carboxy-terminus; 514 
(ii) the CTD selectively binds to H2A-H2B dimers through direct interaction, while the upstream 515 
histone binding domain directly binds to both H2A-H2B and H3-H4 dimers/tetramers with a 516 
preference for H3-H4; (iii) there are striking similarities between nucleosome binding by the IE1 517 
and LANA CTDs. 518 
 519 
Alanine scanning mutagenesis identifies a discrete nucleosome binding motif within 520 
the IE1 CTD. To gain further insight into the physical requirements of IE1-nucleosome complex 521 
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formation, we decided to determine which individual CTD residues contribute to the interaction. 522 
For this purpose, we performed alanine scanning mutagenesis replacing each of the 16 amino 523 
acids comprising the IE1 CTD with alanine (except for A489, which was replaced by glycine) 524 
(Fig. 3A). All mutant CTDs were expressed as GST fusion proteins in E. coli and used in pull-525 
down assays with acid-extracted histones. The IE1 CTD pulled down all four core histones in 526 
these assays, most likely because the experimental conditions (i.e., higher histone concentrations 527 
leading to a larger proportion of octamers compared to Fig. 2B) allowed not only for direct 528 
(H2A-H2B) but also for indirect (H3-H4) interactions. Again, no binding to linker histone H1 529 
was observed. Interestingly, only four CTD residues (H481, M483, T485, and R486) proved to be 530 
essential for histone binding. In addition, six amino acids (S479, T480, P482, V484, S487, and 531 
K488) turned out to augment the interaction significantly. In contrast, mutation of all residues 532 
upstream of S479 (G476, G477, and K478) and downstream of K488 (A489, D490, and Q491) 533 
had no obvious adverse effect on CTD-histone complex formation. In fact, the D490A exchange 534 
appeared to even enhance histone binding compared to the wild-type CTD (Fig. 3B–C). 535 
In order to link the in vitro histone binding results to cellular chromosome association, we 536 
also expressed the wild-type and mutant CTD peptides as fusion proteins with amino-terminal 537 
EGFP in human cells. Co-staining of the EGFP-CTD proteins with mitotic DNA revealed that 538 
each of the same four residues shown to be essential for histone binding (H481, M483, T485, and 539 
R486) is also indispensable for chromosome attachment (Fig. 4AB). Alanine substitution of all 540 
four essential CTD residues or individual substitution of M483 also abolished mitotic chromatin 541 
association of IE1 in the context of the full-length protein (Fig. 4C). Moreover, in agreement with 542 
the binding results, individual exchange of S479, T480, P482, V484, S487, and K488 was linked 543 
to an intermediate phenotype, while mutation of residues at the edges of the IE1 CTD had no 544 
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significant negative (G476, G477, K478, A489, and Q491) or even positive (D490) effects on 545 
chromosome association (Fig. 4A–B).  546 
These results identify a ten-amino-acid nucleosome binding motif (NBM: STHPMVTRSK) 547 
within the IE1 CTD, of which amino acids H481, M483, T485, and R486 are individually 548 
essential for nucleosome core targeting and chromosome attachment (Fig. 4D). 549 
 550 
Histone binding by the IE1 CTD is directed by acidic residues in H2A. In addition to 551 
identifying the viral determinants of IE1-nucleosome complex formation, we set out to probe the 552 
histone-specific contributions. Much of the LANA-nucleosome interaction is mediated by 553 
negatively charged residues in H2A composing the acidic pocket (12). Given the similarities in 554 
histone binding between the LANA and IE1 CTDs (see Fig. 2), each of the nine negatively 555 
charged amino acids found in H2A (including acidic pocket residues E56, E61, E64, D90, E91, 556 
and E92) (Fig. 5A) was individually replaced with alanine. Additionally, we constructed two 557 
triple mutants where H2A residues E61, E64, and D90 or D90, E91, and E92 were 558 
simultaneously changed to alanine. Subsequently, human cells were transfected with plasmids 559 
encoding epitope-tagged wild-type or mutant H2A, and pull-down assays with acid-extracted 560 
histones and GST-IE1476-491 were conducted (Fig. 5B). Interestingly, only mutations in acidic 561 
pocket residues E56, E61, E64, and D90 and the two triple substitutions proved to abolish IE1-562 
H2A binding while all other mutations (E41A, D72A, E91A, E92A, and E121A) had little, if any, 563 
effect on this interaction. 564 
To confirm these results in the context of the full-length IE1 protein, we performed 565 
additional immunoprecipitation-immunoblotting assays (Fig. 5C–D). Again, the E41A, D72A, 566 
E91A, E92A, and E121A substitutions did not diminish (but rather enhanced) IE1 binding 567 
relative to wild-type H2A. However, we reproducibly found reduced binding between the viral 568 
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protein and H2A mutants E56A, E61A, E64A, D90A, and D90A/E91A/E92A. In addition, the 569 
E61A/E64A/D90A mutant exhibited highly impaired IE1 binding. As expected, neither of the 570 
histone mutants was completely defective for binding to the viral protein, most likely due to the 571 
second histone binding domain located upstream of the CTD (see Fig. 2B–C). Correspondingly, 572 
IE11-475 retained some affinity for H2A (Fig. 5C–D). 573 
 These results demonstrate that several negatively charged H2A residues (E56, E61, E64, 574 
and D90) composing the nucleosomal acidic pocket, but not acidic residues outside the pocket, 575 
selectively direct the interaction with the IE1 CTD. 576 
 577 
The IE1 and LANA CTDs compete for binding to nucleosome cores and 578 
chromosomes. Our results indicate that IE1 targets human chromatin via interaction between its 579 
CTD and the acidic pocket formed by H2A-H2B on nucleosome cores (see Fig. 2–5), which 580 
closely resembles the situation described for LANA (12). To further test the idea that the IE1 and 581 
LANA CTDs target the same nucleosomal surface, we asked whether the presence of the IE1 582 
CTD is compatible with or competitive to nucleosome binding by the LANA CTD. First, we 583 
utilized a competition pull-down assay to address this question. GST-LANA5-22 was reacted with 584 
acid-extracted histone octamers and increasing molar ratios of purified IE1. As observed 585 
beforehand for IE1 (see Fig. 3B), histone binding by LANA extended to all four core histone 586 
species under these conditions. However, IE1 diminished complex formation between the LANA 587 
CTD and core histones in a dose-dependent manner (Fig. 6A). Compared to full-length IE1, the 588 
CTD-deficient protein (IE11-475) was much less efficient in competing with GST-LANA5-22 for 589 
histone binding (Fig. 6B). Very similar results were obtained when a synthetic peptide 590 
encompassing the LANA CTD (LANA-CTD) was used to compete with binding between GST-591 
IE1476-491 and core histones, while a mutant peptide (LANA-CTD*) had no effect (Fig. 6C). 592 
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 To gain in vivo support for our assumption that the IE1 and LANA CTDs compete for 593 
binding to nucleosomes, we expressed HA-tagged IE1 and LANA5-22 fused to EGFP in human 594 
cells and examined their localization by immunofluorescence microscopy. In mitotic cells, both 595 
EGFP-LANA5-22 and HA-IE1 predominantly localized to condensed chromatin when expressed 596 
individually (with HA or EGFP, respectively) conforming to previous observations (e.g., 12, 20, 597 
22, 24, 59). However, simultaneous expression of the two proteins resulted in partial release of 598 
EGFP-LANA5-22 and almost complete displacement of HA-IE1 from mitotic chromatin. As 599 
expected, HA-IE1 lacking the CTD (HA-IE11-475) did not attach to chromosomes (Fig. S3). These 600 
results strongly suggest that IE1 and LANA share the same binding site on the nucleosome. 601 
 602 
The IE1 CTD is predicted to form a β-hairpin recognizing the acidic pocket on the 603 
nucleosomal surface. The notion of a shared binding site for IE1 and LANA on the nucleosome 604 
also suggests that key residues responsible for CTD-histone interaction may be conserved 605 
between the two viral proteins. Therefore, we generated alignments between the IE1 and LANA 606 
CTD sequences. The algorithm implemented in PERMOL (54, 62) and most other tested 607 
programs (e. g., ClustalW2, European Bioinformatics Institute) produced an alignment with three 608 
identical residues, one conserved exchange, and two semi-conserved substitutions between 609 
LANA4-17 and IE1476-491 (Fig. 7A). However, the same number of identical residues was also 610 
found with an alternative alignment (Fig. S4A) generated by another program (LALIGN, 611 
European Bioinformatics Institute). The two alignments differ mainly in the way the RS sequence 612 
(R486–S487) in the IE1 CTD is positioned relative to either of two RS sequences (R9–S10 and 613 
R12–S13) in the LANA CTD. Other possible alignments were excluded as they did not involve 614 
the LANA residues known to be required for nucleosome binding (12). 615 
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Based on the two most likely alignments and the available x-ray structure of the LANA 616 
amino-terminal peptide bound to the nucleosome core (Protein Data Bank [PDB]: 1zla), 617 
molecular dynamics-based homology modeling of the IE1 CTD-histone complex was performed. 618 
From the patterns of hydrogen bonds, interatomic distances, and dihedral angles (54, 62) two sets 619 
of restraints (one for each alignment) were created and used to calculate 1,000 structures by 620 
restrained simulated annealing. The ten best structures each in terms of lowest total energy were 621 
refined in explicit water resulting in structural bundles (Fig. 7B and Fig. S4B). The results 622 
suggest that the IE1 CTD can adopt a β-hairpin (two antiparallel β-strands connected by a reverse 623 
turn) resembling the LANA CTD structure. The structural bundle deduced from the first of the 624 
two alignments is well defined with a backbone root-mean-square deviation (RMSD) of 0.038 625 
nm (Fig. 7B). In this model, the β-hairpin formed by the IE1 CTD is stabilized by four main 626 
chain intramolecular hydrogen bonds, and there are ten intermolecular hydrogen bonds between 627 
CTD residues and histones H2A-H2B including amino acids forming the acidic pocket (Fig. 7C). 628 
A three-dimensional representation of this model indicates excellent shape and charge 629 
complementarity between the IE1 CTD and the acidic pocket formed by H2A-H2B including 630 
H2A residues E56, E61, E64, and E92 (Fig. 7D–E and Movie S1). The model derived from the 631 
second alignment is structurally much less well defined exhibiting a backbone RMSD of 0.200 632 
nm (Fig. S4B). Here, the CTD engages in only three intra- and five intermolecular hydrogen 633 
bonds (Fig. S4C). 634 
Although both interaction models largely comply with our in vitro and in vivo data, the in 635 
silico results and conclusions from mutagenesis experiments (see Discussion) favor the model 636 
shown in Fig. 7. 637 
 638 
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The IE1 CTD is dispensable for productive replication of “clinical” hCMV strains. To 639 
address how IE1-nucleosome interaction may impact the course and outcome of infection, BAC 640 
clones of the hCMV low passage strains TB40E (TBwt) and FIX (FXwt) were used to construct 641 
mutant viruses specifically lacking the IE1 CTD (TBIE11-475 and FXIE11-475, respectively). We 642 
also generated “revertant” viruses (TBrvIE11-475 and FXrvIE1) to control for inadvertent genetic 643 
changes. The IE11-475 proteins expressed from the mutant genomes were detected at kinetics and 644 
steady-state levels comparable to full-length IE1 (Fig. 8A–B), and the mutant proteins were 645 
confirmed to be inactive for chromosome association (Fig. 8C–D) in hCMV-infected cells. 646 
 Following infection of permissive fibroblast cells (MRC-5), two independent clones each of 647 
TBIE11-475 and FXIE11-475 did not exhibit significantly altered replication compared to the 648 
corresponding wild-type and revertant strains, neither at high nor low input multiplicities, as 649 
determined by quantification of extracellular viral DNA and infectious particles (Fig. 9). These 650 
findings are consistent with results from a recent study testing a CTD-deleted mutant of the 651 
hCMV high passage strain Towne (23). Thus, nucleosome targeting by IE1 appears to be entirely 652 
dispensable for normal productive hCMV infection in fibroblasts suggesting a function during 653 
non-productive infection and/or infection of other cell types (see Discussion). 654 
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DISCUSSION 655 
 656 
Structural aspects of the IE1-nucleosome interaction. Nucleosomes are the repeating 657 
centerpieces of chromatin (reviewed in 3, 4). Within the nucleosome core, the disordered histone 658 
tail domains are known to engage in interactions with numerous different proteins, while the 659 
folded regions are believed to primarily function in compacting and constraining the DNA. 660 
However, the nucleosome surface is highly contoured and differentially charged (1, 2). The most 661 
distinctive feature of this surface is the acidic pocket, a negatively charged and concave patch 662 
generated by several highly conserved glutamate and aspartate residues contributed by histone 663 
H2A and, to a lesser extent, H2B (reviewed in 63, 64). In fact, the acidic pocket is the only 664 
negatively charged area on the otherwise positive or hydrophobic nucleosomal surface. The 665 
pocket serves no apparent role in maintaining the structure of the nucleosome, but is specifically 666 
recognized by histone H4 tails of adjacent nucleosomes (1, 2) and an increasing number of non-667 
histone cellular and viral proteins. The first protein, besides histone H4, reported to bind to the 668 
acidic pocket was LANA encoded by the γ-herpesvirus KSHV (12). Subsequently, human 669 
interleukin 33 (IL-33) (61), Drosophila melanogaster regulator of chromosome condensation 1 670 
(RCC1) (65), human high-mobility group nucleosomal 2 (HMGN2) protein (66), and 671 
Saccharomyces cerevisiae silent information regulator 3 (Sir3) (67) were all shown or predicted 672 
to interact with the acidic pocket of the nucleosomal core. Furthermore, Foamy virus group-673 
specific antigen (Gag) and Borna disease virus ribonucleoprotein (RNP) were proposed to bind to 674 
host chromosomes via H2A-H2B (68, 69). 675 
The present study identifies the first β-herpesvirus protein targeting the acidic pocket on the 676 
nucleosome. Previous work has demonstrated that the hCMV IE1 protein attaches to human 677 
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mitotic chromosomes through a CTD located at the carboxy-terminus (20, 22, 24). However, the 678 
mechanism of interaction has not been addressed. Although hCMV encodes several chromatin-679 
associated proteins (e.g., 70, 71; reviewed in 72-76), nucleosome binding appears to be a rather 680 
unique feature of IE1. For instance, the hCMV IE2 protein is known to interact with DNA (e.g., 681 
77-80), histones H3-H4 (81), and several histone-associated proteins (e.g., 51, 81-83); however, 682 
IE2 neither associates with condensed chromatin (21, 25) nor with nucleosomes (this work), at 683 
least not to the same extent as IE1. Surprisingly, even mIE1 has little affinity for nucleosomes 684 
and does not co-localize with mitotic chromatin (21, 84 and this work) despite reportedly binding 685 
to DNA and core histones (85, 86). Accordingly, IE1 orthologs of known rodent CMVs 686 
(including mCMV and rat CMV strains) do not seem to exhibit functional CTD sequences (data 687 
not shown). However, CTD and NBM sequences are highly conserved across IE1 proteins of 688 
primate CMVs (Fig. 10) (22). The African green monkey CMV IE1 ortholog has also been 689 
shown to associate with metaphase chromosomes (29). At the same time, sequence similarity 690 
across the full-length orthologous IE1 proteins is limited (Fig. 10). Thus, any available evidence 691 
points to nucleosome targeting being a primate-specific viral adaptation and a distinguishing 692 
feature of primate CMV IE1 proteins. 693 
Our results indicate that the IE1 NBM directly and selectively recognizes the nucleosome 694 
core through the H2A-H2B dimer. In fact, IE1 does not detectably interact with linker histone 695 
H1, and nucleic acids are not required for nucleosome binding by the viral protein. The latter 696 
finding matches the long-standing assumption that hCMV IE1 does not directly bind to DNA 697 
(86), although our data do not exclude this possibility. Despite the fact that the CTD is sufficient 698 
for H2A-H2B binding, nucleosome core interaction, and chromosome association, histone 699 
binding by IE1 is clearly not restricted to the carboxy-terminal domain. Instead, another histone 700 
binding region, which functions independently from the CTD/NBM, must exist upstream of 701 
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amino acid 476. In contrast to the NBM, this region directly binds to all four core histones with a 702 
preference for H3-H4. The fact that all tested H2A mutants retain some affinity for full-length 703 
IE1 suggests that the upstream histone binding domain may interact with H2A-H2B residues 704 
outside the acidic patch. It is tempting to speculate that negatively charged residues within three 705 
proximate acidic stretches (termed acidic domains 1 to 3, AD1–AD3) (21) between amino acids 706 
373 and 475 of IE1 might engage in electrostatic interactions with basic residues of the H3-H4 707 
tetramer and the H2A-H2B dimers. Moreover, the observation that IE11-475 does not associate 708 
with chromosomes and is not required for nucleosome interaction suggests that the upstream 709 
histone binding region may interact with “free” histones rather than nucleosomes.  710 
In most published cases of interactions with the nucleosomal acidic pocket (H4, LANA, IL-711 
33, RCC1, and HMGN2), arginine (and serine) containing linear motifs within conformationally 712 
flexible protein regions contribute to H2A binding. Our work identifies the ten-amino-acid 713 
sequence STHPMVTRSK to be this motif in IE1 (NBM). Results from proton nuclear magnetic 714 
resonance spectroscopy suggest that the IE1 CTD is highly mobile and that this domain is 715 
natively unstructured (data not shown), as has been previously predicted (21). Nonetheless, our 716 
results strongly suggest that the IE1 CTD forms a loop connecting two hydrogen-bonded 717 
antiparallel β-sheets (β-hairpin), at least when complexed with H2A-H2B (“induced fit”). The 718 
predicted IE1 β-hairpin closely resembles the structure previously reported for the complexed 719 
LANA CTD (12). Consequently, the mode of interaction with nucleosomes is strikingly similar 720 
for IE1 and LANA; this is not only evident from our binding and competition experiments, but 721 
also from comparisons between our preferred model and the known crystal structure of the IE1 722 
and LANA CTD-nucleosome complexes, respectively. According to the published structure (12), 723 
LANA4-17 interacts with E61, E64, D90, and E92 of H2A (and several residues of H2B). 724 
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Likewise, our preferred model displays interactions between IE1476-491 and H2A E61, E64, and 725 
E92 (and H2B). In addition, substitution of H2A D90 has a strongly adverse effect on IE1 726 
binding that cannot be directly inferred from the proposed hydrogen bond patterns. However, the 727 
imidazole ring of IE1 H481 is expected to be positively charged in the complex and may thus be 728 
involved in an electrostatic interaction with the nearby negatively charged side chain of H2A 729 
D90. Most likely, the D90A exchange also alters the geometry of the IE1 H481 binding site 730 
within the acidic pocket. Interestingly, our model predicts an additional interaction of IE1476-491 731 
with H2A E56 which has not been described for LANA. The importance of E56 for the IE1-732 
nucleosome interaction is reinforced by our mutational analyses. Moreover, the fact that E56 is 733 
not predicted to contribute to H2A-IE1 binding by our alternative model adds further 734 
experimental support in favor of the preferred model. Taken together, our structural data indicate 735 
that LANA and IE1 target nucleosomes through molecular interactions that are highly similar, 736 
albeit not identical. 737 
 738 
Potential functions of the IE1-nucleosome interaction. Our structural analyses strongly 739 
suggest that the IE1 CTD has specifically evolved to fit the acidic pocket of the nucleosome, and 740 
the CTD/NBM sequences are highly and selectively conserved through primate CMV evolution. 741 
These findings clearly point to an important role of nucleosome targeting by IE1 in hCMV 742 
infection. However, no such role has been reported so far. 743 
Our prior work has demonstrated that nucleosomes are not confined to cellular chromatin, 744 
but also form on hCMV nuclear DNA (87-89). We have also recently shown that global 745 
nucleosome occupancy and dynamics across hCMV genomes are largely controlled by IE1-746 
dependent mechanisms (88). Thus, IE1 may target nucleosomes for active remodeling of viral 747 
and/or cellular chromatin. Notably, interaction between the acidic pocket contributed by H2A-748 
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H2B and a positively charged region of the histone H4 tail from an adjacent nucleosome has been 749 
implicated in the formation of higher-order chromatin structures (90, 91). The H4 tail has no 750 
significant sequence similarity with the IE1 or LANA CTDs (data not shown) and seems to adopt 751 
a different conformation compared to the viral peptides. Moreover, the binding sites of LANA 752 
(and hence also of IE1) and H4 in the acidic pocket do not overlap (2, 12). Nonetheless, the 753 
available structures and models predict that IE1 and LANA may displace the H4 tail from the 754 
pocket raising the possibility that the viral proteins might adversely affect chromatin 755 
condensation. Conceivably, global chromatin decondensation may serve as a mechanism through 756 
which viruses enhance permissiveness of the cellular and/or viral genome to transcriptional 757 
activation and/or other DNA-based processes. Luger and colleagues have examined the effect of 758 
LANA CTD binding on folding and self-association of nucleosome arrays. Against expectations, 759 
they found that LANA stabilizes self-association of nucleosomes and promotes cellular 760 
heterochromatin formation (92). However, these findings somewhat conflict with other reports 761 
(e.g., 93). Likewise, IL-33 appears to regulate chromatin compaction by promoting nucleosome-762 
nucleosome interactions (61). It remains to be determined whether IE1 has any positive or 763 
negative effects on higher-order chromatin structure. 764 
The CTD has been shown to be entirely dispensable for complementing the defective 765 
replication of an IE1-deficient mutant hCMV (Towne) in human fibroblasts (22). Moreover, 766 
mutant viruses of both laboratory-adapted and “clinical” hCMV strains expressing IE11-475 767 
instead of the full-length protein do not display any obvious phenotypic differences compared to 768 
the parental wild-type viruses in these cells (23 and this work). Thus, nucleosome binding by IE1 769 
appears to be irrelevant for hCMV productive infection in fibroblasts. However, IE1-nucleosome 770 
interaction may serve an important function in cell types supporting non-productive (latent) 771 
hCMV infections. More than a decade ago, it was first reported that LANA tethers KSHV 772 
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episomes to host mitotic chromosomes (13, 94), and LANA turned out to be necessary and 773 
sufficient for KSHV episome persistence in the absence of other viral genes. By bridging KSHV 774 
DNA and host chromosomes, LANA facilitates nuclear retention and segregation of viral 775 
episomes to daughter nuclei during viral latency (reviewed in 95). Very similar mechanisms are 776 
used by EBNA1 of EBV and the early 2 (E2) proteins of human and bovine papillomaviruses, 777 
which also tether their respective genomes to cellular chromosomes for efficient maintenance 778 
during cell division (reviewed in 96). As opposed to other DNA viruses, including both α- and γ-779 
herpesviruses, the mechanism of viral genome persistence during latency has remained a mystery 780 
in any of the β-herpesviruses. Thus it is highly tempting to speculate that the IE1-nucleosome 781 
interaction described in this work may contribute to hCMV genome tethering and maintenance. 782 
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Figure Legends 1080 
 1081 
FIG 1  hCMV IE1 interacts with human nucleosomes and all four core histones in a nucleic acid-1082 
independent fashion. 1083 
(A) Results of co-immunoprecipitations from plasmid-transfected cells. H1299 cells were 1084 
transfected with plasmids encoding the indicated HA-tagged viral proteins or with empty vector 1085 
(w/o). Cell extracts were combined with nucleosomes derived from MNase-digested human cell 1086 
nuclei. Samples were subjected to immunoprecipitation using anti-HA or anti-Flag agarose. Input 1087 
and output protein samples were separated in 10 or 15% polyacrylamide-SDS gels, and HA-1088 
tagged proteins and individual core histones were detected by immunoblotting. See also Fig. S1. 1089 
(B) Results of co-immunoprecipitations from hCMV-infected cells. Following infection of MRC-1090 
5 cells with TNwt or TNdlIE1 viruses (3 PFU/cell for 72 h), cells were fixed with formaldehyde, 1091 
and cell extracts were sonicated to solubilize nucleosomes. Samples were subjected to 1092 
immunoprecipitation using rabbit antibodies to histone H3 or non-specific rabbit IgG (rbIgG). 1093 
Input and output protein samples were separated in 15% polyacrylamide-SDS gels, and the IE1 1094 
protein and histone H3 were detected by immunoblotting. 1095 
(C) Results of in vitro GST pull-down assays. Equal volumes of empty glutathione sepharose 1096 
beads or beads carrying GST or GST-IE1 were reacted with acid-extracted human histones in the 1097 
absence or presence of DNase I and RNase A. Input (8% of output) and output protein samples 1098 
were separated in 15% polyacrylamide-SDS gels and stained with Coomassie Brilliant Blue. 1099 
 1100 
FIG 2  hCMV IE1 exhibits two separable histone binding domains with differential specificities 1101 
for H2A-H2B and H3-H4. 1102 
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(A) Schematic of wild-type and mutant hCMV IE1 and KSHV LANA proteins with relative 1103 
locations of their CTDs. 1104 
(B) Results of in vitro GST pull-down assays with acid-extracted unfractionated human histones. 1105 
Empty glutathione sepharose beads or beads carrying GST or the indicated GST fusion proteins 1106 
were reacted with acid-extracted human histones. Input and output protein samples were 1107 
separated along with purified recombinant human core histones (H2A, H2B, H3, and H4 from 1108 
New England Biolabs) in a 15% polyacrylamide-SDS gel and stained with Coomassie Brilliant 1109 
Blue. The asterisk marks H1 histones. 1110 
(C) Results of in vitro GST pull-down assays with acid-extracted human histones separated into 1111 
H2A-H2B and H3-H4 fractions. Equal volumes of empty glutathione sepharose beads or beads 1112 
carrying GST or the indicated GST fusion proteins were reacted with purified human H2A-H2B 1113 
or H3-H4. Input (8% of output) and output protein samples were separated in 15% 1114 
polyacrylamide-SDS gels and stained with Coomassie Brilliant Blue. 1115 
 1116 
FIG 3  Alanine scanning mutagenesis identifies IE1 CTD residues critical for histone binding. 1117 
(A) Presentation of wild-type (wt) and mutant IE1476-491 protein sequences. Amino acids 1118 
substituted by alanine scanning mutagenesis are highlighted. 1119 
(B) Results of in vitro GST pull-down assays. Glutathione sepharose beads carrying GST or the 1120 
indicated wild-type (wt) and mutant GST-IE1476-491 fusion proteins (see also Fig. 3A) were 1121 
reacted with acid-extracted histones. Input (14% of output) and output protein samples were 1122 
separated in 15% polyacrylamide-SDS gels and stained with Coomassie Brilliant Blue. 1123 
(C) Quantitative assessment of GST pull-down assay results. The output bands were quantified 1124 
by densitometry, and bars represent the ratio of histones H3, H2B, H2A, and H4 to GST-IE1476-1125 
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491. Results for the CTD mutants are presented relative to the CTD wt sample present on the same 1126 
gel (set to 100%). 1127 
 1128 
FIG 4  Alanine scanning mutagenesis identifies IE1 CTD residues critical for mitotic chromatin 1129 
association. 1130 
(A) Results of co-localization analyses in mitotic cells. H1299 cells were transfected with 1131 
plasmids encoding EGFP or the indicated wild-type (wt) and mutant EGFP-IE1476-491 fusion 1132 
proteins (see also Fig. 3A). Cells were fixed with methanol, immunostained for EGFP, and 1133 
counterstained for DNA with DAPI. Representative individual and merged images of EGFP and 1134 
DAPI signals are presented. 1135 
(B) Quantitative assessment of co-localization analysis results. The extent of overlap between 1136 
pixels in the green and blue channels was quantified by calculating Pearson’s correlation 1137 
coefficients (1 = perfect positive correlation, 0 = no correlation, -1 = perfect negative 1138 
correlation). Bars represent means from at least three randomly selected mitotic cell images with 1139 
standard deviations. A Student’s t-test was performed to check for statistical significance of 1140 
differences between CTD wt and the respective mutant (* p <0.1, ** p <0.01). 1141 
(C) Assessment of essential CTD residues in the background of full-length IE1. H1299 cells were 1142 
transfected with pCMV.TetO-derived plasmids encoding wild-type IE1, IE11-475, or full-length 1143 
IE1 with alanine substitutions of all four (IE1 NBM) or one single (IE1 M483A) CTD residue 1144 
determined to be essential in (A) and (B). Cells were fixed with methanol, immunostained for 1145 
IE1, and counterstained for DNA with DAPI. Representative individual and merged images of 1146 
IE1 and DAPI signals are presented. 1147 
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(D) Delineation of the nucleosome binding motif (NBM) within the IE1 CTD as deduced from 1148 
data shown in (A), (B), (C), and Fig. 3. Amino acids determined to be essential or accessory for 1149 
histone binding and chromatin association are highlighted. 1150 
 1151 
FIG 5  Site-directed mutagenesis identifies human H2A residues critical for interaction with IE1. 1152 
(A) H2A residues targeted by mutagenesis and evaluated for contributions to IE1 binding. The 1153 
complete sequence of human histone H2A.2 (H2A type 1-B/E) is shown, with acidic residues in 1154 
bold letters and amino acids forming the acidic pocket underlined. 1155 
(B) Results of in vitro GST pull-down assays performed with the IE1 CTD. Empty glutathione 1156 
sepharose beads or beads carrying GST-IE1476-491 were reacted with acid-extracted human 1157 
histones from H1299 cells transfected with empty vector (w/o) or plasmids encoding the 1158 
indicated Flag-tagged H2A proteins. Input and output protein samples were separated in 15% 1159 
polyacrylamide-SDS gels and stained with Coomassie Brilliant Blue. Flag-H2A proteins were 1160 
detected by immunoblotting. 1161 
(C) Results of co-immunoprecipitations performed with full-length IE1 protein. H1299 cells were 1162 
simultaneously transfected with empty vector (w/o) or plasmids encoding the indicated wild-type 1163 
(wt) and mutant Flag-H2A proteins and plasmids encoding either HA-tagged full-length IE1 or 1164 
HA-IE11-475. Cells were fixed with formaldehyde, and cell extracts were sonicated to solubilize 1165 
nucleosomes. Samples were subjected to immunoprecipitation using anti-HA or mouse IgG 1166 
(mIgG) agarose. Input and output protein samples were separated in 10 or 15% polyacrylamide-1167 
SDS gels, and Flag- and HA-tagged proteins were detected by immunoblotting. 1168 
- 55 - 
 
(D) Quantitative assessment of results. The α-Flag bands shown in (C) were quantified by 1169 
densitometry, and bars represent the ratio of output to input signal intensities relative to the H2A 1170 
wt sample present on the same blot (set to 100%). 1171 
 1172 
FIG 6  The IE1 and LANA CTDs compete for binding to human core histones. 1173 
(A) Full-length IE1 competes with GST-LANA5-22 for histone binding. 1174 
(B) IE1 lacking the CTD (IE11-475) is less active in competing with GST-LANA5-22 for histone 1175 
binding compared to the full-length protein. 1176 
(C) A peptide encompassing LANA5-22 (LANA-CTD), but not a mutant peptide (LANA-CTD*), 1177 
interferes with histone binding to GST-IE1476-491. 1178 
Acid-extracted human histones were combined with solvent or with the indicated soluble IE1 1179 
proteins (A, B) or LANA peptides (C) and then subjected to in vitro GST pull-down assays with 1180 
glutathione sepharose beads carrying GST-LANA5-22 (A, B) or GST-IE1476-491 (C). Input and 1181 
output protein samples were separated in 15% polyacrylamide-SDS gels and stained with 1182 
Coomassie Brilliant Blue. See also Fig. S3. 1183 
 1184 
FIG 7  The IE1 CTD is predicted to adopt a β-hairpin structure that docks with the acidic pocket 1185 
formed by H2A-H2B on the nucleosomal surface. 1186 
(A) Amino acid sequence alignment of IE1476-491 and LANA4-17 (* = identical residue, : = 1187 
conserved substitution, . = semi-conserved substitution) used for homology modeling. 1188 
(B) Bundles of the ten lowest total energy structures for IE1476-491 after explicit water refinement 1189 
(RMSD = 0.038 nm) based on the sequence alignment of (A) and the LANA4-17-nucleosome 1190 
crystal structure (PDB: 1zla). 1191 
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(C) Predicted intra- and intermolecular hydrogen bonds in the IE1476-491-nucleosome complex 1192 
based on the sequence alignment of (A) and the LANA4-17-nucleosome crystal structure (PDB: 1193 
1zla). Black arrows symbolize predicted interactions between IE1 CTD and H2A or H2B 1194 
residues also observed in the LANA-nucleosome complex, and red arrows represent predicted 1195 
interactions unique to the IE1-nucleosome complex. Arrow tails define the donor and arrow 1196 
heads point at the acceptor of a possible hydrogen bond. 1197 
(D) Front view of detailed total best energy homology model of the molecular interaction 1198 
between IE1476-491 and the H2A-H2B dimer based on the sequence alignment of (A) and the 1199 
LANA4-17-nucleosome crystal structure after explicit water refinement. The model is presented as 1200 
displayed in PyMOL (http://www.pymol.org) (97) showing the H2A-H2B dimer in surface 1201 
representation. Blue color represents positively charged and red color negatively charged side 1202 
chains. The H2A residues predicted or experimentally determined to be critical for binding to 1203 
IE1476-491 (see Fig. 5) are indicated. The IE1476-491 peptide is shown in a ball-and-stick 1204 
representation. IE1 residues P482 and R486 are marked by arrows for better orientation. 1205 
(E) Model (D) after 90° turn in indicated direction. See also Fig. S4 and Movie S1. 1206 
 1207 
FIG 8  Steady-state levels and chromatin association of wild-type and mutant IE1 proteins in 1208 
hCMV-infected cells. 1209 
(A) IE1 and IE2 steady-state protein levels in hCMV TB40E infections. MRC-5 cells were mock-1210 
infected or infected with TBwt, TBrvIE11-475, or TBIE11-475 at 3 PFU/cell, and viral IE1/IE2 1211 
protein levels were monitored over time by separation in 10% polyacrylamide-SDS gels and 1212 
immunoblotting. Detection of the cellular GAPDH protein served as a loading control. 1213 
(B) IE1 and IE2 steady-state protein levels in hCMV FIX infections. MRC-5 cells were mock-1214 
infected or infected with FXwt, FXrvIE1, or FXIE11-475 at 3 PFU/cell, and viral IE1/IE2 protein 1215 
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levels were monitored over time by separation in 10% polyacrylamide-SDS gels and 1216 
immunoblotting. Detection of the cellular GAPDH protein served as a loading control. 1217 
(C) Mitotic chromatin association of IE1 in hCMV TB40E infections. MRC-5 cells were mock-1218 
infected or infected with TBwt, TBrvIE11-475, or TBIE11-475 at 3 PFU/cell for 48 h, and the 1219 
localization of the viral IE1 protein relative to cellular mitotic chromatin (stained with DAPI) was 1220 
detected by indirect immunofluorescence using a 1:1 mix of antibodies IE1.G10 and 6E1. 1221 
(D) Mitotic chromatin association of IE1 in hCMV FIX infections. MRC-5 cells were mock-1222 
infected or infected with FXwt, FXrvIE1, or FXIE11-475 at 3 PFU/cell for 48 h, and the 1223 
localization of the viral IE1 protein relative to cellular mitotic chromatin (stained with DAPI) was 1224 
detected by indirect immunofluorescence using antibody IE1.G10. 1225 
 1226 
FIG 9  The IE1 CTD is not required for efficient hCMV productive infection. 1227 
(A) Single-step replication analysis of TB40E viruses. MRC-5 cells were infected with TBwt, 1228 
TBrvIE11-475, or TBIE11-475 (two independent clones) at high input multiplicity (3 PFU/cell), and 1229 
extracellular viral genomes were monitored over time by qPCR-based relative quantification. 1230 
Data represent means and standard deviations from duplicate infections each measured twice 1231 
(TBwt at 0 days post infection set to 1). 1232 
(B) Peak virus titers in high multiplicity TB40E infections. Extracellular infectious particles from 1233 
7 days post infection (A) were quantified by standard plaque assay on MRC-5 cells. Data 1234 
represent means and standard deviations from duplicate infections each measured twice. 1235 
(C) Multi-step replication analysis of TB40E viruses. MRC-5 cells were infected with TBwt, 1236 
TBrvIE11-475, or TBIE11-475 (two independent clones) at low input multiplicity (0.03 PFU/cell), 1237 
and extracellular viral genomes were monitored over time by qPCR-based relative quantification. 1238 
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Data represent means and standard deviations from duplicate infections each measured twice 1239 
(TBwt at 0 days post infection set to 1). 1240 
(D) Peak virus titers in low multiplicity TB40E infections. Extracellular infectious particles from 1241 
16 days post infection (C) were quantified by standard plaque assay on MRC-5 cells. Data 1242 
represent means and standard deviations from duplicate experiments each measured twice. 1243 
(E) Single-step replication analysis of FIX viruses. MRC-5 cells were infected with FXwt, 1244 
FXrvIE1, or FXIE11-475 (two independent clones) at high input multiplicity (3 PFU/cell), and 1245 
extracellular viral genomes were monitored over time by qPCR-based relative quantification. 1246 
Data represent means and standard deviations from duplicate infections each measured twice 1247 
(FXwt at 0 days post infection set to 1). 1248 
(F) Peak virus titers in high multiplicity FIX infections. Extracellular infectious particles from 6 1249 
days post infection (E) were quantified by standard plaque assay on MRC-5 cells. Data represent 1250 
means and standard deviations from duplicate infections each measured twice. 1251 
(G) Multi-step replication analysis of FIX viruses. MRC-5 cells were infected with FXwt, 1252 
FXrvIE1, or FXIE11-475 (two independent clones) at low input multiplicity (0.05 PFU/cell), and 1253 
extracellular viral genomes were monitored over time by qPCR-based relative quantification. 1254 
Data represent means and standard deviations from duplicate infections each measured twice 1255 
(FXwt at 0 days post infection set to 1). 1256 
(H) Peak virus titers in low multiplicity FIX infections. Extracellular infectious particles from 15 1257 
days post infection (G) were quantified by standard plaque assay on MRC-5 cells. Data represent 1258 
means and standard deviations from duplicate infections each measured twice. 1259 
 1260 
FIG 10  The IE1 NBM is selectively conserved through primate CMV evolution. 1261 
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(A) Alignment of orthologous IE1 sequences from hCMV (Towne) and all non-human primate 1262 
CMV isolates present in GenBank (National Center for Biotechnology Information) (98) 1263 
including chimpanzee CMV (panine herpesvirus 2), african green monkey (simian) CMV 1264 
(cercopithecine herpesvirus 5), rhesus macaque CMV (Macaca mulatta CMV and Macacine 1265 
herpesvirus 3, 68-1 strain), and baboon CMV. The multiple sequence alignment was generated 1266 
using ClustalW2 (European Bioinformatics Institute; http://www.ebi.ac.uk/tools/msa/clustalw2) 1267 
with default settings and rendered using Jalview 2.7 (http://www.jalview.org) (99). The extent of 1268 
amino acid conservation is visualized by shades of blue. CTD and NBM sequences are marked. 1269 
(B) Table presenting GenBank accession numbers of orthologous IE1 sequences from primate 1270 
CMVs and % amino acid sequence identities of full-length IE1 proteins, IE1 CTDs, and IE1 1271 
NBMs relative to the corresponding hCMV IE1 (Towne) sequence based on pairwise alignments 1272 
(IE1) or the multiple sequence alignment shown in (A) (CTD, NBM). 1273 
(C) Sequence logo illustrating extent of amino acid conservation in orthologous IE1 CTD 1274 
sequences from primate CMVs. The sequence logo was generated using WebLogo 2.8.2 1275 
(http://weblogo.berkeley.edu) (100) with default color code. Amino acids are numbered 1276 
according to their positions in the hCMV (Towne) IE1 sequence. Numbers corresponding to 1277 
amino acids forming the hCMV IE1 NBM are printed in bold type, and residues essential for 1278 
nucleosome and chromosome interaction are underlined. 1279 
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